Cardiovascular diseases (CVDs) have become a significant health concern in India, leading to a high incidence rate of mortality and disability. According to the World Health Organization (WHO), the death rate for CVDs in India is 272 per one lakh population, which is higher than the global average of 235. In recent years, the prevalence of CVDs in India has increased rapidly due to lifestyle changes and risk factors such as hypertension, diabetes mellitus, dyslipidemia, physical inactivity, diet, and addiction.
Cardiovascular diseases (CVDs) are a significant cause of mortality worldwide. In India, CVDs account for 28 percent of all deaths, with ischemic heart disease and stroke being the two most common causes. To combat this rising issue, the medical industry has emphasized the need for technology-driven investigative and therapeutic modalities, including imaging, cath lab, angiographic radiographic tools, contrast agents, and electronically implanted cardiovascular devices. Cardiovascular devices have become instrumental in diagnosing and managing arrhythmia, heart failure, coronary artery disease, valvular heart disease, and other heart conditions. With increasing economic status and a growing focus on healthcare, there has been a significant rise in the adoption levels of advanced cardiovascular devices, promoting medical tourism.
India has a higher mortality rate due to CVDs in the 40-69 year age group, and the incidence of the disease is spreading like a mini-pandemic. Diagnostic tools such as Electrocardiogram machines, Echocardiography (USG), Holter monitoring, X-ray, CT, and MRI are used to diagnose and treat major cardiovascular conditions and improve the quality of life. USG devices, such as 2D echo, are used to analyze cardiac functions and detect structural cardiac abnormalities.
Bu hikaye Healthcare Radius dergisinin April 2023 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye Healthcare Radius dergisinin April 2023 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
Dengue-related searches surge on Justdial
Justdial data reveals significant increase in dengue-related searches and pest control services this monsoon season, amid severe dengue outbreak in India.
Ipca launches NovaLead's Diulcus for diabetic foot ulcer
Ipca Laboratories launches NovaLead's patented drug Diulcus, for the treatment of diabetic foot ulcer in India.
Sahyadri Hospitals unveils advanced radiotherapy treatment
Sahyadri Hospitals launches Asia's first advanced radiotherapy treatment, Radixact X9 system with Vital Hold technology for precise cancer treatment.
Complex liver transplant saves diabetic patient
Wockhardt Hospitals, Mumbai Central and South Asian Liver Institute provide liver transplant services to a Botswanian patient.
Gynecological cancers rise in young Indian women
Experts stress need for awareness, early screening, and advanced treatment options like robotic-assisted surgery for gynecological cancers.
Mahajan Imaging, Siemens unveil AI diagnostic analyzer
Mahajan Imaging and Labs and Siemens Healthineers launch India's first Al-diagnostic analyzer.
Nimotuzumab boosts head and neck cancer survival - Tata Memorial study
A Tata Memorial study finds Nimotuzumab increases 10-year survival rate for head and neck cancer patients.
Kolkata doctor rape and murder: Everything you wanted to know
Protesting doctors demand better workplace safety and stricter policy measures.
AYUSH treatments to be covered under PM-JAY?
Very soon, AYUSH treatments may be covered under AB PM-JAY.
WHAT DOCTORS MUST TELL PATIENTS ABOUT DRY EYE SYNDROME
Dry eye syndrome affects lakhs of people globally, causing discomfort and vision issues. Learn how doctors must guide patients about managing it.